Reappraising preoperative ctDNA in EGFR-mutant NSCLC: from detection to responsible clinical integration.
APA
Sun M, Zang D, Chen J (2025). Reappraising preoperative ctDNA in EGFR-mutant NSCLC: from detection to responsible clinical integration.. Lung cancer (Amsterdam, Netherlands), 210, 108846. https://doi.org/10.1016/j.lungcan.2025.108846
MLA
Sun M, et al.. "Reappraising preoperative ctDNA in EGFR-mutant NSCLC: from detection to responsible clinical integration.." Lung cancer (Amsterdam, Netherlands), vol. 210, 2025, pp. 108846.
PMID
41270640
같은 제1저자의 인용 많은 논문 (5)
- Clinical outcomes and immune contexture in SMARCA4-deficient gastric cancer patients.
- Prolonged survival with alectinib in a patient with advanced lung adenocarcinoma: a case report and literature review.
- Clarifying the survival impact of immunotherapy in HR+/HER2- metastatic breast cancer: methodological caveats from a real-world perspective - Letter to the Editor.
- Magnetic resonance-guided simultaneous multi-focal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.
- Rethinking AI-based prediction of NAT response in breast cancer: toward mechanistic and subtype-aware modeling - Letter to the Editor.